- Home
- GTIM vs QNRX Comparison
GTIM vs QNRX Comparison
Compare GTIM & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GTIM | QNRX |
|---|---|---|
| Founded | 1987 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6M | 14.5M |
| IPO Year | 2013 | 2023 |
Fundamental Metrics
Financial Performance| Metric | GTIM | QNRX |
|---|---|---|
| Price | $1.27 | $6.34 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 31.4K | 25.0K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $142,315,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $63.99 | ★ N/A |
| Revenue Growth | ★ 3.01 | N/A |
| 52 Week Low | $1.10 | $5.20 |
| 52 Week High | $2.09 | $41.80 |
Technical Indicators
Market Signals| Indicator | GTIM | QNRX |
|---|---|---|
| Relative Strength Index (RSI) | 55.83 | 46.86 |
| Support Level | $1.24 | $5.47 |
| Resistance Level | $1.29 | $6.98 |
| Average True Range (ATR) | 0.03 | 0.45 |
| MACD | -0.00 | 0.12 |
| Stochastic Oscillator | 40.04 | 65.72 |
Price Performance
Historical ComparisonAbout GTIM Good Times Restaurants Inc.
Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants, which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants, which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers, chicken, frozen custard; slides and drinks.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.